Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

253.85
BATS BZX Real-Time Price
As of 12:55pm ET
 +2.88 / +1.15%
Today’s Change
184.50
Today|||52-Week Range
261.27
+20.88%
Year-to-Date
Allergan Break Out
12:41pm / TheStreet.com - Paid Partner Content
PFG Financial Advisors Buys iShares Core S&P Mid-Cap, iShares Core S&P Small-Cap, ...
Jul 21 / GuruFocus News - Paid Partner Content
Trump Could Still Unleash an Attack on Amazon Real Soon, Doug Kass Says
Jul 22 / TheStreet.com - Paid Partner Content
State of Play
Jul 20 / TheStreet.com - Paid Partner Content
Financial Architects, Inc Buys International Business Machines Corp, Salesforce. ...
Jul 21 / GuruFocus News - Paid Partner Content
Oakbrook Investments Llc Buys Schlumberger, JPMorgan Chase, Visa Inc, Sells W.W. ...
Jul 20 / GuruFocus News - Paid Partner Content
Cedar Wealth Management, LLC Buys Vanguard Total International Stock ETF, Vanguard Sh...
Jul 21 / GuruFocus News - Paid Partner Content
The World's Largest Generic Drugmaker Is Plunging
Jul 19 / GuruFocus News - Paid Partner Content
APG All Pensions Group NV Buys Valero Energy Corp, Allergan PLC, Allergan PLC, Sells ...
Jul 21 / GuruFocus News - Paid Partner Content
Equitec Specialists, Llc Buys Dominion Energy Inc, Arconic Inc, Welltower Inc, Sells ...
Jul 19 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close250.97
Today’s open250.53
Day’s range249.69 - 254.53
Volume73,756
Average volume (3 months)2,227,408
Market cap$84.3B
Dividend yield1.10%
Data as of 12:55pm ET, 07/24/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.94%
Earnings growth (next 5 years)+14.85%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.15-0.44%
NVONovo Nordisk-0.94-2.19%
ABTAbbott Laboratories+0.01+0.03%
BMYBristol-Myers Squibb+0.07+0.13%
Data as of 12:56pm ET, 07/24/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$3.92
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts